<table id="ID114" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 13. Established and Other Potentially Significant Drug Interactions</caption>
<col width="31%"></col>
<col width="25%"></col>
<col width="44%"></col>
<tfoot>
<tr>
<td align="left" colspan="3">
<paragraph stylecode="Footnote">↓ = Decreased (induces lamotrigine glucuronidation).
             
     
      <br/>
</paragraph>
</td>
</tr>
<tr>
<td align="left" colspan="3">
<paragraph stylecode="Footnote">↑ = Increased (inhibits lamotrigine glucuronidation).
             
     
      <br/>
</paragraph>
</td>
</tr>
<tr>
<td align="left" colspan="3">
<paragraph stylecode="Footnote">? = Conflicting data.
             
     
      <br/>
</paragraph>
</td>
</tr>
</tfoot>
<tbody>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="bottom">Concomitant Drug 
            
    
     <br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="bottom">Effect on Concentration of 
            
    
     <br/>Lamotrigine or Concomitant Drug 
            
    
     <br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="bottom">Clinical Comment 
            
    
     <br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="middle">Estrogen-containing oral 
            
    
     <br/>contraceptive 
            
    
     <br/>preparations containing 30 mcg 
            
    
     <br/>ethinylestradiol and 150 mcg levonorgestrel 
            
    
     <br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="middle">↓ lamotrigine 
            
    
     <br/>
<br/>↓ levonorgestrel 
            
    
     <br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="middle">Decreased lamotrigine concentrations approximately 50%. 
            
    
     <br/>
<br/>Decrease in levonorgestrel component by 19%. 
            
    
     <br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="middle">Carbamazepine and carbamazepine epoxide 
            
    
     <br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="middle">↓ lamotrigine 
            
    
     <br/>
<br/>
<br/>? carbamazepine epoxide 
            
    
     <br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="middle">Addition of carbamazepine decreases 
            
    
     <br/>lamotrigine concentration approximately 40%. 
            
    
     <br/>May increase carbamazepine epoxide levels. 
            
    
     <br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="middle">Lopinavir/ritonavir 
            
    
     <br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="middle">↓ lamotrigine 
            
    
     <br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="middle">Decreased lamotrigine concentration approximately 50%. 
            
    
     <br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="middle">Atazanavir/ritonavir 
            
    
     <br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="middle">↓ lamotrigine
            
    
     <br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="middle">Decreased lamotrigine AUC approximately 32%. 
            
    
     <br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="middle">Phenobarbital/Primidone 
            
    
     <br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="middle">↓ lamotrigine 
            
    
     <br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="middle">Decreased lamotrigine concentration
            
    
     <br/> approximately 40%. 
            
    
     <br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="middle">Phenytoin 
            
    
     <br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="middle">↓ lamotrigine 
            
    
     <br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="middle">Decreased lamotrigine concentration 
            
    
     <br/>approximately 40%. 
            
    
     <br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="middle">Rifampin 
            
    
     <br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="middle">↓ lamotrigine 
            
    
     <br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="middle">Decreased lamotrigine AUC 
            
    
     <br/>approximately 40%. 
            
    
     <br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="middle">Valproate 
            
    
     <br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↑ lamotrigine
            
    
     <br/>
<br/> ? valproate 
            
    
     <br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="middle">Increased lamotrigine concentrations 
            
    
     <br/>slightly more than 2-fold. 
            
    
     <br/>There are conflicting study results regarding effect of lamotrigine on valproate concentrations: 1) a mean 25% decrease in valproate concentrations in healthy volunteers, 2) no change in valproate concentrations in controlled clinical trials in patients with epilepsy.
            
    
     <br/>
</td>
</tr>
</tbody>
</table>